This web site is part of the Business Intelligence Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Boehringer Ingelheim GmbH
Drug Names(s): nevirapine extended release, NVP XR
Description: This is a once-daily extended release formulation of Viramune, a non-nucleoside reverse transcriptase inhibitor (NNRTI).
Viramune XR News
Pink Sheet September Supplemental Approvals
Additional information available to subscribers only: